Invention Grant
- Patent Title: Cysteine protease
-
Application No.: US15550309Application Date: 2016-02-12
-
Publication No.: US10696959B2Publication Date: 2020-06-30
- Inventor: Christian Kjellman , Sofia Jarnum , Emma Nordahl
- Applicant: HANSA MEDICAL AB
- Applicant Address: SE Lund
- Assignee: HANSA BIOPHARMA AB
- Current Assignee: HANSA BIOPHARMA AB
- Current Assignee Address: SE Lund
- Agency: Norton Rose Fulbright US LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@67115b53
- International Application: PCT/EP2016/053052 WO 20160212
- International Announcement: WO2016/128558 WO 20160818
- Main IPC: C12N9/52
- IPC: C12N9/52 ; C12N9/54 ; A61K38/48 ; A61K38/00
Abstract:
The present invention relates to a novel polypeptide which displays IgG cysteine protease activity, and in vivo and ex vivo uses thereof. Uses of the polypeptide include methods for the prevention or treatment of diseases and conditions mediated by IgG, and methods for the analysis of IgG.
Public/Granted literature
- US20180023070A1 CYSTEINE PROTEASE Public/Granted day:2018-01-25
Information query
IPC分类:
